TR200200745T2 - Fenilasetik asit türevleri için proses. - Google Patents

Fenilasetik asit türevleri için proses.

Info

Publication number
TR200200745T2
TR200200745T2 TR2002/00745T TR200200745T TR200200745T2 TR 200200745 T2 TR200200745 T2 TR 200200745T2 TR 2002/00745 T TR2002/00745 T TR 2002/00745T TR 200200745 T TR200200745 T TR 200200745T TR 200200745 T2 TR200200745 T2 TR 200200745T2
Authority
TR
Turkey
Prior art keywords
acid derivatives
phenylacetic acid
formula
precursors
compound
Prior art date
Application number
TR2002/00745T
Other languages
English (en)
Inventor
Acemo�Lu Murat
Allmendinger Thomas
Vincet Calienni John
Cercus Jacques
Loiseleur Olivier
Sedelmeier Gottfried
Xu David
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR200200745T2 publication Critical patent/TR200200745T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • C07C211/56—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Abstract

Içerisindeki sembollerin, istemlerde tanimlandigi gibi oldugu formül (II)'deki bir laktamin, bir baz ile bölünmesini içeren, formül (I)'deki bir bilesik, veya bunun farmasötik olarak kabul edilebilir bir tuzu, veya bunun farmasötik olarak kabul edilebilir bir ön-ilaç esterinin üretimi için proses; ve söz konusu bilesik için öncüler (precursors) ve söz konusu öncülerin hazirlanmasi için prosesler. Formül (I)'deki bilesikler; Siklooksijenaz II'nin selektif inhibitörleri olan, farmasötik olarak aktif bilesiklerdir.
TR2002/00745T 1999-09-27 2000-09-25 Fenilasetik asit türevleri için proses. TR200200745T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922830.6A GB9922830D0 (en) 1999-09-27 1999-09-27 Processes

Publications (1)

Publication Number Publication Date
TR200200745T2 true TR200200745T2 (tr) 2002-06-21

Family

ID=10861676

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00745T TR200200745T2 (tr) 1999-09-27 2000-09-25 Fenilasetik asit türevleri için proses.

Country Status (34)

Country Link
US (2) US20080249318A1 (tr)
EP (2) EP1216226B1 (tr)
JP (1) JP2003510303A (tr)
KR (1) KR100745341B1 (tr)
CN (1) CN100412053C (tr)
AR (2) AR031529A1 (tr)
AT (1) ATE447547T1 (tr)
AU (1) AU775416B2 (tr)
BR (1) BR0014314A (tr)
CA (1) CA2379553C (tr)
CO (1) CO5210865A1 (tr)
CY (1) CY1110539T1 (tr)
CZ (1) CZ20021027A3 (tr)
DE (1) DE60043261D1 (tr)
DK (1) DK1216226T3 (tr)
EC (2) ECSP003680A (tr)
ES (1) ES2338209T3 (tr)
GB (1) GB9922830D0 (tr)
HK (1) HK1047739A1 (tr)
HU (1) HUP0202728A3 (tr)
IL (2) IL148330A0 (tr)
MY (1) MY125201A (tr)
NO (1) NO327912B1 (tr)
NZ (1) NZ517461A (tr)
PE (1) PE20010644A1 (tr)
PL (1) PL207777B1 (tr)
PT (1) PT1216226E (tr)
RU (1) RU2273628C2 (tr)
SI (1) SI1216226T1 (tr)
SK (1) SK287241B6 (tr)
TR (1) TR200200745T2 (tr)
TW (1) TWI270540B (tr)
WO (1) WO2001023346A2 (tr)
ZA (1) ZA200202367B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
CA2487414A1 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
AR042206A1 (es) 2002-11-26 2005-06-15 Novartis Ag Acidos fenilaceticos y derivados
US7161026B1 (en) 2005-07-08 2007-01-09 Property Development Corporation International, Ltd, Inc. Method of preparation of methyl-benzyl-ketone
AR061623A1 (es) 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
WO2010056741A2 (en) 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Phenylacetic acid inhibitors of cyclooxygenase
CN102311355B (zh) * 2011-09-26 2014-02-05 扬州天和药业有限公司 罗本考昔的一种制备方法
CN107721901A (zh) * 2017-11-12 2018-02-23 刘磊 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法
WO2020021077A1 (en) 2018-07-27 2020-01-30 Krka, D.D., Novo Mesto A process for the preparation of polymorphic form of robenacoxib
JP6708319B1 (ja) * 2018-08-03 2020-06-10 日産化学株式会社 フッ化芳香族第二級アミン化合物の製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IT1097265B (it) 1978-06-23 1985-08-31 Acraf Nouva sintesi di un acido fenilacetico
JPS5677246A (en) * 1980-11-27 1981-06-25 Nissan Chem Ind Ltd Production of substituted phenylacetic acid
DE3404401C2 (de) 1984-02-08 1994-02-10 Hoechst Ag Verwendung von Aryloxy-Verbindungen als Antidots
FR2578836B1 (fr) 1985-03-12 1987-04-17 Rhone Poulenc Spec Chim Procede de chloration selective de composes phenoliques
ATE116636T1 (de) * 1989-01-27 1995-01-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
IT1248032B (it) * 1991-06-11 1995-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della n- (2,6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CN1091420A (zh) * 1993-02-25 1994-08-31 永信药品工业股份有限公司 二苯胺衍生物的制备方法
JPH0789951A (ja) 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−１β転換酵素阻害剤
US5475139A (en) * 1993-10-22 1995-12-12 Yung Shin Pharm. Ind. Co., Ltd. Method for the preparation of substituted derivatives of diphenyl amine
MX9605196A (es) 1994-04-29 1997-12-31 Sanofi Winthrop Inc Halometilamidas como inhibidores de la proteasa il-1b.
US5576460A (en) * 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
JPH0977664A (ja) * 1995-09-13 1997-03-25 Yakult Honsha Co Ltd シクロオキシゲナーゼ−２特異的阻害剤及び抗炎症剤
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US6034266A (en) * 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
BR9600975A (pt) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivados do ácido gem-difluorfenilacético e de gem-difluorfenilacetamida processo de sua preparação e suas aplicações farmacêuticas
CA2208900C (en) 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
US5817877A (en) * 1996-09-23 1998-10-06 Yale University Metal-catalyzed amination of organic sulfonates to organic amines
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados

Also Published As

Publication number Publication date
HUP0202728A2 (hu) 2002-12-28
PL207777B1 (pl) 2011-01-31
DK1216226T3 (da) 2010-02-01
CA2379553C (en) 2010-09-21
ATE447547T1 (de) 2009-11-15
RU2273628C2 (ru) 2006-04-10
TWI270540B (en) 2007-01-11
PL365994A1 (en) 2005-01-24
ECSP093680A (es) 2009-02-27
AU775416B2 (en) 2004-07-29
CY1110539T1 (el) 2015-04-29
IL148330A0 (en) 2002-09-12
US20090275758A1 (en) 2009-11-05
SK4142002A3 (en) 2002-08-06
AU7906700A (en) 2001-04-30
ECSP003680A (es) 2002-04-23
MY125201A (en) 2006-07-31
KR20020030289A (ko) 2002-04-24
CN1377337A (zh) 2002-10-30
CN100412053C (zh) 2008-08-20
IL148330A (en) 2007-02-11
GB9922830D0 (en) 1999-11-24
NO20021368D0 (no) 2002-03-19
NZ517461A (en) 2003-10-31
KR100745341B1 (ko) 2007-08-02
EP2275403A1 (en) 2011-01-19
PE20010644A1 (es) 2001-06-15
NO20021368L (no) 2002-05-27
NO327912B1 (no) 2009-10-19
AR042404A2 (es) 2005-06-22
SK287241B6 (sk) 2010-04-07
US20080249318A1 (en) 2008-10-09
PT1216226E (pt) 2009-12-17
CA2379553A1 (en) 2001-04-05
EP1216226A2 (en) 2002-06-26
ZA200202367B (en) 2003-02-26
HK1047739A1 (en) 2003-03-07
CO5210865A1 (es) 2002-10-30
US7906677B2 (en) 2011-03-15
HUP0202728A3 (en) 2003-11-28
JP2003510303A (ja) 2003-03-18
EP1216226B1 (en) 2009-11-04
AR031529A1 (es) 2003-09-24
SI1216226T1 (sl) 2010-03-31
WO2001023346A2 (en) 2001-04-05
WO2001023346A3 (en) 2002-01-10
DE60043261D1 (de) 2009-12-17
BR0014314A (pt) 2002-11-12
ES2338209T3 (es) 2010-05-05
CZ20021027A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
NZ506329A (en) Inhibitors of phospholipase enzymes
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
JO2282B1 (en) Oxazole derivatives
DK0931788T3 (da) Metalloproteasehæmmere
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MY137562A (en) 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
HUP0401647A2 (hu) Új béta-fenil-alfa-oxi-propionsav-származékok, előállítási eljárásaik és gyógyszerészetileg fontos vegyületek előállításánál történő felhasználásuk
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20025590D0 (no) Fenylglycin-derivater
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
TR200200745T2 (tr) Fenilasetik asit türevleri için proses.
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
JO2413B1 (en) Benzoxazine derivatives and their use
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
SE9803773D0 (sv) Compounds
TR200100286T2 (tr) (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses.
TR200102395T2 (tr) Fenilalaninol türevleri.
DE60020130D1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
MXPA04005210A (es) Procedimiento para la preparacion de composiciones que tienen una cantidad incrementada de sales farmaceuticamente activas de rotameros.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen
NO20042729L (no) Heksasykliske forbindelser